Spain OKs Bentley cancer drug
Bentley Pharmaceuticals has won its first approval to market a genetic cancer drug in Spain, a $65 million market, the company announced Wednesday. The Exeter-based generic pharmaceuticals company, whose major subsidiary and marketing is in Europe, particularly Spain, said the…
